In Vivo Effects of Myocardial Creatine Depletion on Left Ventricular Function, Morphology, and Energy Metabolism-Consequences in Acute Myocardial Infarction

Journal of Cardiac Failure

Volumn 13, Issue 3, 2007, Pages 230-237

  Lorentzon, Malin ^a   Råmunddal, Truls ^a   Bollano, Entela ^a   Soussi, Bassam ^a   Waagstein, Finn ^a   Omerovic, Elmir ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

31P magnetic resonance spectroscopy; Cardiac remodeling; Congestive heart failure; Energy metabolism; Ventricular arrhythmias

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE 3' PHOSPHATE; CATECHOLAMINE; CREATINE; CREATINE PHOSPHATE; GUANIDINOPROPIONIC ACID;

ACUTE HEART INFARCTION; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENERGY METABOLISM; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LEFT CORONARY ARTERY; MALE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; STRESS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; ARRHYTHMIA; BIOLOGICAL MARKERS; CATECHOLAMINES; CREATINE; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; ENERGY METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34247091922     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.11.012     Document Type: Article

References (35)

1. Ryden-Bergsten T., and Andersson F. The health care costs of heart failure in Sweden. J Intern Med 246 (1999) 275-284
2. Ho K.K., Pinsky J.L., Kannel W.B., et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22 (1993) 6
3. McMurray J.J., and Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 83 (2000) 596-602
4. Hardy C.J., Weiss R.G., Bottomley P.A., et al. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 122 (1991) 795-801
5. Conway M.A., Allis J., Ouwerkerk R., et al. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 338 (1991) 973-976
6. Ingwall J.S., Kramer M.F., Fifer M.A., et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 313 (1985) 1050-1054
7. Neubauer S., Krahe T., Schindler R., et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86 (1992) 1810-1818
8. Horn M., Remkes H., Stromer H., et al. Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation 104 (2001) 1844-1849
9. Ingwall J.S., and Shen W. The chemistry of the ATP in the failing heart. Heart Failure Rev 4 (1999) 221-228
10. Ingwall J.S. Is cardiac failure a consequence of decreased energy reserve?. Circulation 87 (1993) VII-58-62
11. Ingwall J.S. Do changes in the creatine kinase system contribute to ventricular dysfunction in the failing heart? Current and future applications of magnetic resonance in cardiovascular disease (1998), Gothenburg University, Gothenburg, Sweden
12. Neubauer S., Remkes H., Spindler M., et al. Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation 100 (1999) 1847-1850
13. Mekhfi H., Hoerter J., Lauer C., et al. Myocardial adaptation to creatine deficiency in rats fed with beta-guanidinopropionic acid, a creatine analogue. Am J Physiol 258 (1990) H1151-H1158
14. Horn M., Frantz S., Remkes H., et al. Effects of chronic dietary creatine feeding on cardiac energy metabolism and on creatine content in heart, skeletal muscle, brain, liver and kidney. J Mol Cell Cardiol 30 (1998) 277-284
15. Neubauer S., Hu K., Horn M., et al. Functional and energetic consequences of chronic myocardial creatine depletion by beta-guanidinopropionate in perfused hearts and in intact rats. J Mol Cell Cardiol 31 (1999) 1845-1855
16. Murphy R., McConell G., Cameron-Smith D., et al. Creatine transporter protein content, localization, and gene expression in rat skeletal muscle. Am J Physiol Cell Physiol 280 (2001) C415-C422
17. Snow R.J., and Murphy R.M. Creatine and the creatine transporter: a review. Mol Cell Biochem 224 (2001) 169-181
18. Omerovic E., Bollano E., Madhu B., et al. Bioenergetic, functional and morphologic consequences of postinfarct cardiac remodeling in the rat. J Mol Cell Cardiol 31 (1999) 1685-1695
19. Bollano E., Waagstein F., and Omerovic E. Stress echocardiography using transesophageal atrial pacing in rats. J Am Soc Echocardiogr 16 (2003) 326-332
20. Opitz C.F., Finn P.V., Pfeffer M.A., et al. Effects of reperfusion on arrhythmias and death after coronary artery occlusion in the rat: increased electrical stability independent of myocardial salvage. J Am Coll Cardiol 32 (1998) 261-267
21. Johnston K.M., MacLeod B.A., and Walker M.J. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can J Physiol Pharmacol 61 (1983) 1340-1353
22. Curtis M.J., and Hearse D.J. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol 21 (1989) 21-40
23. Kujacic M., Hansson L.O., and Carlsson A. Acute dopaminergic influence on plasma adrenaline levels in the rat. Eur J Pharmacol 273 (1995) 247-257
24. Rundqvist B., Elam M., Bergmann-Sverrisdottir Y., et al. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95 (1997) 169-175
25. Dhalla N.S., Kaura D., Liu X., et al. Mechanisms of subcellular remodelling in post-infarct heart failure. EXS 76 (1996) 463-477
26. Sharpe N. Cardiac remodeling in coronary artery disease. Am J Cardiol 93 Suppl 1 (2004) 17-20
27. Horn M., Remkes H., Stromer H., et al. Chronic phosphocreatine depletion by the creatine analogue {beta}-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation 104 (2001) 1844-1849
28. Ingwall J.S. Creatine and the control of muscle-specific protein synthesis in cardiac and skeletal muscle. Circ Res 38 (1976) I115-I123
29. Wallis J., Lygate C.A., Fischer A., et al. Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation 112 (2005) 3131-3139
30. Goldman S., Johnson G., Cohn J.N., et al. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group. Circulation 87 6 Suppl (1993) VI24-VI31
31. Solomon S.D., Zelenkofske S., McMurray J.J.V., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
32. Abraham M.R., Selivanov V.A., Hodgson D.M., et al. Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. J Biol Chem 277 (2002) 24427-24434
33. Mihm M.J., Yu F., Carnes C.A., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
34. Kahan T., and Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart 91 (2005) 250-256
35. Ravingerova T., Neckar J., Kolar F., et al. Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia?. Basic Res Cardiol 96 (2001) 160-168